Enlivex Therapeutics Ltd (ENLV) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ENLV Annual Balance Sheets →
The balance sheet data below highlights changes in Enlivex Therapeutics Ltd's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash & cash equivalent1.58
Marketable Securities, Current SH0.00
Other Short-term Investments AS3.86
Cash & Short-term Investments4.00
Other Receivables, Net, Current0.24
Notes Receivable, Current0.16
Discontinued Operations0.00
Other Current Assets1,733.06
Prepaid Expense And Other Assets Current4.36
Total Current Assets1,743.18
Equipment/Property/Plant Net3.31
Long-term investments2.37
Financial Instruments0.01
Tax Assets, Noncurrent2.24
Prepaid Expense, Noncurrent, Total PR0.00
Other Assets, Noncurrent583.46
Total Assets2,327.00
Liabilities
Accounts Payable, Trade, Current3.81
Accrued Liabilities, Current AC5.21
Total Current Liabilities9.02
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent382.65
Other liabilities, Noncurrent0.00
Total Liabilities392.05
Stockholders' Equity
Common Stock Value28.73
Additional Paid In Capital Common Stock796.70
Retained Earnings / Accumulated Deficit1,108.42
Accumulated Other Comprehensive Income1.10
Other Equity1.10
Common Stockholder's Equity1,934.95
Total Stockholder's Equity1,934.95
Liabilities & Stockholder's Equity2,327.00
4 historic quarters locked

Sign in to unlock the full Enlivex Therapeutics Ltd balance sheet history.

About Enlivex Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-033857

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.